相关实验视频
Updated: Jun 26, 2025

10:31
Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
12.4K
[兰伯特-伊顿骨髓缩综合征] 这是什么?
1Department of Neurology, National Hospital Organization Nagasaki National Hospital.
Brain and nerve = Shinkei kenkyu no shinpo
|May 14, 2024
概括
兰伯特-伊顿肌综合征 (LEMS) 是一种自身免疫性疾病,由于对电压通道的抗体而导致肌肉衰弱. 诊断包括电生理学和抗体测试,治疗包括瘤治疗和3,4-氨酸胺.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 兰伯特-伊顿肌综合征 (LEMS) 是一种罕见的自身免疫性疾病,影响神经肌肉结节.
- 它表现为近端肌肉软弱,反射减弱和自主功能障碍.
- 患病率大约为每10万人口中的0.25-0.27.
研究的目的:
- 总结兰伯特-伊顿肌痛综合征的诊断标准和治疗策略.
- 要突出LEMS和小细胞肺癌 (SCLC) 之间的关联.
- 为LEMS管理提供当前临床实践指南的概述.
主要方法:
- 对诊断标准的审查,包括日本LEMS诊断标准 2022.
- 对致病性自身抗体的分析,特别是P/Q型电压通道 (VGCC) 抗体.
- 检查治疗方式:瘤,免疫治疗和症状.
主要成果:
- 在LEMS中肌肉衰弱是由对预突触VGCCs的自身抗体引起的.
- 显著的百分比 (50-60%) 的LEMS患者有相关的SCLC.
- P/Q型VGCC抗体阳性是一个强有力的诊断指标.
- 在大多数患者中,3,4-diaminopyridine是有效的症状治疗.
结论:
- 准确的LEMS诊断依赖于电生理学发现和肌症状.
- 有效的瘤治疗可以改善SCLC患者的LEMS症状.
- 已建立的治疗算法指导LEMS管理,包括瘤学,免疫治疗和症状方法.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
791
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
791
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Disorders of the Skeletal Muscle
932
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
932
Cross-bridge Cycle
117.4K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.4K
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Muscle Contraction
6.4K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
6.4K

